Language Selector:

Lungpacer Medical, Inc. Announces the Completion of First-In-Human Early Feasibility Study

BURNABY, British Columbia, May 2016

Lungpacer Medical, Inc., a medical device company developing an intravenous catheter-based phrenic-nerve-pacing system, announced today their completion of the enrollment into the Phrenic ACtivation for Enhanced Respiration (PACER) early feasibility study conducted in Paraguay. The study enrolled a total of 28 subjects and showed that stimulation of the phrenic nerves, via the LIVE Catheter, was able to elicit diaphragm contractions in synchrony with mechanical ventilation.